TPW
AZN icon

Transatlantique Private Wealth’s AstraZeneca AZN Stock Holding History

Transatlantique Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.75M Sell
23,624
-81
-0.3% -$14.2K 2.74% 4
2025
Q3 		$7.11M Buy
+23,705
New +$3.59M 2.33% 6

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Transatlantique Private Wealth's AZN Position: Q4 2025 in Review

Transatlantique Private Wealth reduced its AstraZeneca (AZN) stake by 0.34% in Q4 2025, selling an estimated $14.2K and leaving 23,624 shares worth $8.75M. The position accounts for 2.74% of the portfolio, ranked #4.

Transatlantique Private Wealth first reported a position in AZN in Q3 2025 and has held it in 2 quarters since. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Transatlantique Private Wealth held 23,624 shares of AstraZeneca worth $8.75M as of Q4 2025.
  • Transatlantique Private Wealth sold 81 AstraZeneca shares in Q4 2025, an estimated $14.2K.
  • AstraZeneca made up 2.74% of Transatlantique Private Wealth's portfolio in Q4 2025, its #4 holding.
  • Transatlantique Private Wealth first reported a position in AstraZeneca in Q3 2025 and has held it in 2 quarters since.
  • 1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.